Published in Proc Natl Acad Sci U S A on July 18, 2000
Convergence of Wnt, beta-catenin, and cadherin pathways. Science (2004) 13.13
TGFβ signalling in context. Nat Rev Mol Cell Biol (2012) 8.08
Signaling cross-talk between TGF-beta/BMP and other pathways. Cell Res (2009) 3.66
TGF-beta-induced repression of CBFA1 by Smad3 decreases cbfa1 and osteocalcin expression and inhibits osteoblast differentiation. EMBO J (2001) 2.81
Snail and Slug promote epithelial-mesenchymal transition through beta-catenin-T-cell factor-4-dependent expression of transforming growth factor-beta3. Mol Biol Cell (2008) 2.78
Beta-catenin is required for endothelial-mesenchymal transformation during heart cushion development in the mouse. J Cell Biol (2004) 2.57
The establishment of Spemann's organizer and patterning of the vertebrate embryo. Nat Rev Genet (2000) 2.51
Signaling mechanisms of the epithelial-mesenchymal transition. Sci Signal (2014) 2.42
CCN1/Cyr61 is regulated by the canonical Wnt signal and plays an important role in Wnt3A-induced osteoblast differentiation of mesenchymal stem cells. Mol Cell Biol (2006) 2.15
Smad3-dependent nuclear translocation of beta-catenin is required for TGF-beta1-induced proliferation of bone marrow-derived adult human mesenchymal stem cells. Genes Dev (2006) 2.15
Integrity of cell-cell contacts is a critical regulator of TGF-beta 1-induced epithelial-to-myofibroblast transition: role for beta-catenin. Am J Pathol (2004) 2.09
Cooperation between snail and LEF-1 transcription factors is essential for TGF-beta1-induced epithelial-mesenchymal transition. Mol Biol Cell (2006) 2.06
T-cell factors: turn-ons and turn-offs. EMBO J (2002) 2.00
Axin and GSK3- control Smad3 protein stability and modulate TGF- signaling. Genes Dev (2008) 1.93
Bone morphogenetic protein 2 induces pulmonary angiogenesis via Wnt-beta-catenin and Wnt-RhoA-Rac1 pathways. J Cell Biol (2009) 1.77
LEF1-mediated regulation of Delta-like1 links Wnt and Notch signaling in somitogenesis. Genes Dev (2004) 1.76
TGFbeta3 inhibits E-cadherin gene expression in palate medial-edge epithelial cells through a Smad2-Smad4-LEF1 transcription complex. J Cell Sci (2007) 1.73
Activation of LIMK1 by binding to the BMP receptor, BMPRII, regulates BMP-dependent dendritogenesis. EMBO J (2004) 1.70
Axin facilitates Smad3 activation in the transforming growth factor beta signaling pathway. Mol Cell Biol (2001) 1.69
TGFbeta3 signaling activates transcription of the LEF1 gene to induce epithelial mesenchymal transformation during mouse palate development. J Cell Biol (2003) 1.67
Colorectal cancer: genetics of development and metastasis. J Gastroenterol (2006) 1.63
Integrin alpha3beta1-dependent beta-catenin phosphorylation links epithelial Smad signaling to cell contacts. J Cell Biol (2009) 1.58
Microarray gene expression profiling of osteoarthritic bone suggests altered bone remodelling, WNT and transforming growth factor-beta/bone morphogenic protein signalling. Arthritis Res Ther (2007) 1.47
Axin is a scaffold protein in TGF-beta signaling that promotes degradation of Smad7 by Arkadia. EMBO J (2006) 1.47
The p53 Family Coordinates Wnt and Nodal Inputs in Mesendodermal Differentiation of Embryonic Stem Cells. Cell Stem Cell (2016) 1.46
Cloning of the human GLI2 Promoter: transcriptional activation by transforming growth factor-beta via SMAD3/beta-catenin cooperation. J Biol Chem (2009) 1.45
The notch intracellular domain can function as a coactivator for LEF-1. Mol Cell Biol (2001) 1.45
β-catenin signaling: a novel mediator of fibrosis and potential therapeutic target. Curr Opin Rheumatol (2011) 1.41
Interaction between Smad7 and beta-catenin: importance for transforming growth factor beta-induced apoptosis. Mol Cell Biol (2005) 1.41
Beta-catenin controls differentiation of the retinal pigment epithelium in the mouse optic cup by regulating Mitf and Otx2 expression. Development (2009) 1.39
Wnt/β-catenin signaling activates bone morphogenetic protein 2 expression in osteoblasts. Bone (2012) 1.38
MicroRNA-21 induces stemness by downregulating transforming growth factor beta receptor 2 (TGFβR2) in colon cancer cells. Carcinogenesis (2011) 1.33
The effects of myostatin on adipogenic differentiation of human bone marrow-derived mesenchymal stem cells are mediated through cross-communication between Smad3 and Wnt/beta-catenin signaling pathways. J Biol Chem (2008) 1.32
The LEF1/beta -catenin complex activates movo1, a mouse homolog of Drosophila ovo required for epidermal appendage differentiation. Proc Natl Acad Sci U S A (2002) 1.27
PITX2 and beta-catenin interactions regulate Lef-1 isoform expression. Mol Cell Biol (2007) 1.26
Wnt signaling in eye organogenesis. Organogenesis (2008) 1.21
Post-translational regulation of TGF-β receptor and Smad signaling. FEBS Lett (2012) 1.21
Interaction between the transforming growth factor-beta type II receptor/Smad pathway and beta-catenin during transforming growth factor-beta1-mediated adherens junction disassembly. Am J Pathol (2002) 1.19
Wnt-mediated regulation of chondrocyte maturation: modulation by TGF-beta. J Cell Biochem (2005) 1.18
Smad signaling in skeletal development and regeneration. Cytokine Growth Factor Rev (2009) 1.17
Smad3 prevents beta-catenin degradation and facilitates beta-catenin nuclear translocation in chondrocytes. J Biol Chem (2010) 1.16
Beta-catenin in the fibroproliferative response to acute lung injury. Am J Respir Cell Mol Biol (2005) 1.15
Signal integration in TGF-β, WNT, and Hippo pathways. F1000Prime Rep (2013) 1.15
Epigenetic regulation of DACH1, a novel Wnt signaling component in colorectal cancer. Epigenetics (2013) 1.13
Endoglin and Alk5 regulate epithelial-mesenchymal transformation during cardiac valve formation. Dev Biol (2006) 1.13
Rac1 GTPase and the Rac1 exchange factor Tiam1 associate with Wnt-responsive promoters to enhance beta-catenin/TCF-dependent transcription in colorectal cancer cells. Mol Cancer (2008) 1.12
TGF-β regulates β-catenin signaling and osteoblast differentiation in human mesenchymal stem cells. J Cell Biochem (2011) 1.11
Microtubule stabilization by bone morphogenetic protein receptor-mediated scaffolding of c-Jun N-terminal kinase promotes dendrite formation. Mol Cell Biol (2010) 1.10
HEF1, a novel target of Wnt signaling, promotes colonic cell migration and cancer progression. Oncogene (2011) 1.10
Differential control of Wnt target genes involves epigenetic mechanisms and selective promoter occupancy by T-cell factors. Mol Cell Biol (2007) 1.09
Cell-context dependent TCF/LEF expression and function: alternative tales of repression, de-repression and activation potentials. Crit Rev Eukaryot Gene Expr (2011) 1.09
Identification of mZnf8, a mouse Krüppel-like transcriptional repressor, as a novel nuclear interaction partner of Smad1. Mol Cell Biol (2002) 1.08
TGF-beta signaling in chondrocytes. Front Biosci (2005) 1.08
Smad2 functions as a co-activator of canonical Wnt/beta-catenin signaling pathway independent of Smad4 through histone acetyltransferase activity of p300. Cell Signal (2008) 1.08
An integrative ChIP-chip and gene expression profiling to model SMAD regulatory modules. BMC Syst Biol (2009) 1.08
Smad4 cooperates with lymphoid enhancer-binding factor 1/T cell-specific factor to increase c-myc expression in the absence of TGF-beta signaling. Proc Natl Acad Sci U S A (2006) 1.06
Urothelial transdifferentiation to prostate epithelia is mediated by paracrine TGF-beta signaling. Differentiation (2008) 1.04
Wnt signaling in vertebrate axis specification. Cold Spring Harb Perspect Biol (2013) 1.03
Functional interactions between Dlx2 and lymphoid enhancer factor regulate Msx2. Nucleic Acids Res (2006) 1.03
TGF-beta1 and WISP-1/CCN-4 can regulate each other's activity to cooperatively control osteoblast function. J Cell Biochem (2008) 1.03
Activation of Wnt11 by transforming growth factor-β drives mesenchymal gene expression through non-canonical Wnt protein signaling in renal epithelial cells. J Biol Chem (2012) 1.02
Nanowire-mediated delivery enables functional interrogation of primary immune cells: application to the analysis of chronic lymphocytic leukemia. Nano Lett (2012) 1.01
Tcf3 inhibits spinal cord neurogenesis by regulating sox4a expression. Development (2009) 1.00
Mesodermal fate decisions of a stem cell: the Wnt switch. Cell Mol Life Sci (2008) 0.99
Inhibition of Wnt/Axin/beta-catenin pathway activity promotes ventral CNS midline tissue to adopt hypothalamic rather than floorplate identity. Development (2004) 0.98
Relevance of the stroma and epithelial-mesenchymal transition (EMT) for the rheumatic diseases. Arthritis Res Ther (2006) 0.97
Mad is required for wingless signaling in wing development and segment patterning in Drosophila. PLoS One (2009) 0.97
Characterization of a transient TCF/LEF-responsive progenitor population in the embryonic mouse retina. Invest Ophthalmol Vis Sci (2008) 0.96
Requirement of TCF7L2 for TGF-beta-dependent transcriptional activation of the TMEPAI gene. J Biol Chem (2010) 0.96
Phosphorylation of Mad controls competition between wingless and BMP signaling. Sci Signal (2011) 0.95
Application of an integrated physical and functional screening approach to identify inhibitors of the Wnt pathway. Mol Syst Biol (2009) 0.94
SMAD regulatory networks construct a balanced immune system. Immunology (2013) 0.93
Prognostic significance of BMP and activin membrane-bound inhibitor in colorectal cancer. World J Gastroenterol (2008) 0.93
Cloning and developmental expression of mouse pygopus 2, a putative Wnt signaling component. Genomics (2004) 0.93
Wnts are expressed in the spinal cord of adult mice and are differentially induced after injury. J Neurotrauma (2014) 0.92
Jerky/Earthbound facilitates cell-specific Wnt/Wingless signalling by modulating β-catenin-TCF activity. EMBO J (2011) 0.92
β-Catenin-independent activation of TCF1/LEF1 in human hematopoietic tumor cells through interaction with ATF2 transcription factors. PLoS Genet (2013) 0.91
The evolving roles of canonical WNT signaling in stem cells and tumorigenesis: implications in targeted cancer therapies. Lab Invest (2015) 0.91
Wnt pathway in pulmonary fibrosis in the bleomycin mouse model. J Environ Pathol Toxicol Oncol (2009) 0.91
Cross-talk between transforming growth factor-beta and Wingless/Int pathways in lung development and disease. Int J Biochem Cell Biol (2010) 0.91
High-resolution chromatin immunoprecipitation (ChIP) sequencing reveals novel binding targets and prognostic role for SOX11 in mantle cell lymphoma. Oncogene (2014) 0.88
The Notch ligand Delta-like 1 integrates inputs from TGFbeta/Activin and Wnt pathways. Exp Cell Res (2011) 0.88
Canonical Wnt signalling requires the BMP pathway to inhibit oligodendrocyte maturation. ASN Neuro (2011) 0.87
Paracrine Wnt1 Drives Interstitial Fibrosis without Inflammation by Tubulointerstitial Cross-Talk. J Am Soc Nephrol (2015) 0.86
A systems biological approach to identify key transcription factors and their genomic neighborhoods in human sarcomas. Chin J Cancer (2011) 0.86
Inhibition of Drosophila Wg signaling involves competition between Mad and Armadillo/beta-catenin for dTcf binding. PLoS One (2008) 0.86
Pathogenesis of colorectal carcinoma and therapeutic implications: the roles of the ubiquitin-proteasome system and Cox-2. J Cell Mol Med (2007) 0.84
Foxc2 induces Wnt4 and Bmp4 expression during muscle regeneration and osteogenesis. Cell Death Differ (2013) 0.83
Intrinsic properties of Tcf1 and Tcf4 splice variants determine cell-type-specific Wnt/β-catenin target gene expression. Nucleic Acids Res (2012) 0.83
A re-evaluation of two key reagents for in vivo studies of Wnt signaling. Dev Dyn (2011) 0.82
Investigating tonic Wnt signaling throughout the adult CNS and in the hippocampal neurogenic niche of BatGal and ins-TopGal mice. Cell Mol Neurobiol (2012) 0.82
Nmp4/CIZ inhibits mechanically induced beta-catenin signaling activity in osteoblasts. J Cell Physiol (2010) 0.82
Analysis of differentially expressed genes and signaling pathways related to intramuscular fat deposition in skeletal muscle of sex-linked dwarf chickens. Biomed Res Int (2014) 0.82
Stem cells in gastrointestinal cancers: The road less travelled. World J Stem Cells (2014) 0.81
Arhgef7 promotes activation of the Hippo pathway core kinase Lats. EMBO J (2014) 0.81
Efficient retina formation requires suppression of both Activin and BMP signaling pathways in pluripotent cells. Biol Open (2015) 0.80
Identification of DNA-dependent protein kinase catalytic subunit as a novel interaction partner of lymphocyte enhancer factor 1. Med Mol Morphol (2013) 0.80
Limited TCF7L2 expression in MS lesions. PLoS One (2013) 0.80
Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma. Science (1997) 22.80
TGF-beta signal transduction. Annu Rev Biochem (1998) 17.83
TGF-beta signalling from cell membrane to nucleus through SMAD proteins. Nature (1997) 15.75
Wnt signaling: a common theme in animal development. Genes Dev (1997) 12.94
Smads: transcriptional activators of TGF-beta responses. Cell (1998) 5.33
Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas. Proc Natl Acad Sci U S A (1998) 4.99
MADR2 is a substrate of the TGFbeta receptor and its phosphorylation is required for nuclear accumulation and signaling. Cell (1996) 4.70
Synergy between tumor suppressor APC and the beta-catenin-Tcf4 target Tcf1. Science (1999) 4.08
Modulation of transcriptional regulation by LEF-1 in response to Wnt-1 signaling and association with beta-catenin. Mol Cell Biol (1998) 3.79
Beta-catenin: a key mediator of Wnt signaling. Curr Opin Genet Dev (1998) 3.65
LEF-1, a nuclear factor coordinating signaling inputs from wingless and decapentaplegic. Cell (1997) 3.63
Regulation of LEF-1/TCF transcription factors by Wnt and other signals. Curr Opin Cell Biol (1999) 3.52
Smad2 and Smad3 positively and negatively regulate TGF beta-dependent transcription through the forkhead DNA-binding protein FAST2. Mol Cell (1998) 3.36
Interaction between Wnt and TGF-beta signalling pathways during formation of Spemann's organizer. Nature (2000) 3.35
Smads and early developmental signaling by the TGFbeta superfamily. Genes Dev (1998) 3.07
Smads as transcriptional co-modulators. Curr Opin Cell Biol (2000) 2.92
Specific activation of Smad1 signaling pathways by the BMP7 type I receptor, ALK2. J Biol Chem (1998) 2.72
Regulation of Smad activity. Cell (2000) 2.53
TCF/LEF factor earn their wings. Trends Genet (1997) 2.19
The Xenopus homeobox gene twin mediates Wnt induction of goosecoid in establishment of Spemann's organizer. Development (1997) 1.77
The vestigial gene product provides a molecular context for the interpretation of signals during the development of the wing in Drosophila. Development (1999) 1.14
Cooperation between the activin and Wnt pathways in the spatial control of organizer gene expression. Proc Natl Acad Sci U S A (1998) 1.11
TGF beta signals through a heteromeric protein kinase receptor complex. Cell (1992) 8.12
Mechanism of activation of the TGF-beta receptor. Nature (1994) 8.10
Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2. Nat Genet (1996) 5.15
MADR2 is a substrate of the TGFbeta receptor and its phosphorylation is required for nuclear accumulation and signaling. Cell (1996) 4.70
SARA, a FYVE domain protein that recruits Smad2 to the TGFbeta receptor. Cell (1998) 4.51
MADR2 maps to 18q21 and encodes a TGFbeta-regulated MAD-related protein that is functionally mutated in colorectal carcinoma. Cell (1996) 4.13
MADR1, a MAD-related protein that functions in BMP2 signaling pathways. Cell (1996) 3.87
The daf-4 gene encodes a bone morphogenetic protein receptor controlling C. elegans dauer larva development. Nature (1993) 3.45
Smad2 and Smad3 positively and negatively regulate TGF beta-dependent transcription through the forkhead DNA-binding protein FAST2. Mol Cell (1998) 3.36
TbetaRI phosphorylation of Smad2 on Ser465 and Ser467 is required for Smad2-Smad4 complex formation and signaling. J Biol Chem (1997) 3.03
Myostatin signals through a transforming growth factor beta-like signaling pathway to block adipogenesis. Mol Cell Biol (2003) 2.90
Type I receptors specify growth-inhibitory and transcriptional responses to transforming growth factor beta and activin. Mol Cell Biol (1994) 2.59
The TGF-beta family and its composite receptors. Trends Cell Biol (1994) 2.36
Synergistic cooperation between hypoxia and transforming growth factor-beta pathways on human vascular endothelial growth factor gene expression. J Biol Chem (2001) 2.14
Signaling activity of transforming growth factor beta type II receptors lacking specific domains in the cytoplasmic region. Mol Cell Biol (1993) 1.98
Characterization and relationship of Dpp receptors encoded by the saxophone and thick veins genes in Drosophila. Cell (1994) 1.94
Identification of two bone morphogenetic protein type I receptors in Drosophila and evidence that Brk25D is a decapentaplegic receptor. Cell (1994) 1.76
The Xenopus dorsalizing factor noggin ventralizes Drosophila embryos by preventing DPP from activating its receptor. Cell (1996) 1.64
FoxH1 (Fast) functions to specify the anterior primitive streak in the mouse. Genes Dev (2001) 1.47
Assignment of transforming growth factor beta1 and beta3 and a third new ligand to the type I receptor ALK-1. J Biol Chem (1999) 1.44
Medea is a Drosophila Smad4 homolog that is differentially required to potentiate DPP responses. Development (1998) 1.44
Role of endoglin in cellular responses to transforming growth factor-beta. A comparative study with betaglycan. J Biol Chem (1998) 1.44
Mutations in the tumor suppressors Smad2 and Smad4 inactivate transforming growth factor beta signaling by targeting Smads to the ubiquitin-proteasome pathway. Proc Natl Acad Sci U S A (2000) 1.43
The Smad pathway. Cytokine Growth Factor Rev (2000) 1.34
Transcriptional regulation by Smads: crosstalk between the TGF-beta and Wnt pathways. J Bone Joint Surg Am (2001) 1.33
Two distinct transmembrane serine/threonine kinases from Drosophila melanogaster form an activin receptor complex. Mol Cell Biol (1994) 1.32
BMP-2 and OP-1 exert direct and opposite effects on renal branching morphogenesis. Am J Physiol (1997) 1.29
Cross-talk between the p42/p44 MAP kinase and Smad pathways in transforming growth factor beta 1-induced furin gene transactivation. J Biol Chem (2001) 1.25
Mothers against dpp participates in a DDP/TGF-beta responsive serine-threonine kinase signal transduction cascade. Development (1997) 1.24
Identification of a Drosophila activin receptor. Proc Natl Acad Sci U S A (1993) 1.23
MAD-related proteins in TGF-beta signalling. Trends Genet (1996) 1.18
Dominant-negative Smad2 mutants inhibit activin/Vg1 signaling and disrupt axis formation in Xenopus. Dev Biol (1999) 1.14
The RING-H2 protein RNF11 is overexpressed in breast cancer and is a target of Smurf2 E3 ligase. Br J Cancer (2003) 1.14
Mouse NKR-P1B, a novel NK1.1 antigen with inhibitory function. J Immunol (1999) 1.05
TGF-beta receptors. Mol Reprod Dev (1992) 1.03
Signaling activity of homologous and heterologous transforming growth factor-beta receptor kinase complexes. J Biol Chem (1995) 1.01
The type II TGF-beta receptor signals diverse responses in cooperation with the type I receptor. Cold Spring Harb Symp Quant Biol (1992) 0.93
Involvement of Smads in TGFbeta1-induced furin (fur) transcription. J Cell Physiol (2001) 0.90
Histone H3 thiol reactivity and acetyltransferases in chicken erythrocyte nuclei. J Biol Chem (1988) 0.85
mRNAs for activin receptors II and IIB are expressed in mouse oocytes and in the epiblast of pregastrula and gastrula stage mouse embryos. Mech Dev (1995) 0.84
Volume regulation of Chinese hamster ovary cells in anisoosmotic media. Biochim Biophys Acta (1984) 0.83
Mothers against decapentaplegic-related protein 2 expression in avian granulosa cells is up-regulated by transforming growth factor beta during ovarian follicular development. Endocrinology (1997) 0.77
Characterization of Smad phosphorylation and Smad-receptor interaction. Methods Mol Biol (2000) 0.76
The use of recombinant vaccinia virus to generate monoclonal antibodies against the cell-surface glycoprotein endoglin. FEBS Lett (1997) 0.76